Literature DB >> 19240056

National health spending by medical condition, 1996-2005.

Charles Roehrig1, George Miller, Craig Lake, Jenny Bryant.   

Abstract

This study responds to recent calls for information about how personal health expenditures from the National Health Expenditure Accounts are distributed across medical conditions. It provides annual estimates from 1996 through 2005 for thirty-two conditions mapped into thirteen all-inclusive diagnostic categories. Circulatory system spending was highest among the diagnostic categories, accounting for 17 percent of spending in 2005. The most costly conditions were mental disorders and heart conditions. Spending growth rates were lowest for lung cancer, chronic obstructive pulmonary disease, pneumonia, coronary heart disease, and stroke, perhaps reflecting benefits of preventive care.

Entities:  

Mesh:

Year:  2009        PMID: 19240056     DOI: 10.1377/hlthaff.28.2.w358

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  48 in total

1.  Potential national and state medical care savings from primary disease prevention.

Authors:  Barbara A Ormond; Brenda C Spillman; Timothy A Waidmann; Kyle J Caswell; Bogdan Tereshchenko
Journal:  Am J Public Health       Date:  2010-11-18       Impact factor: 9.308

2.  Trends and disparities in heart disease mortality among American Indians/Alaska Natives, 1990-2009.

Authors:  Mark Veazie; Carma Ayala; Linda Schieb; Shifan Dai; Jeffrey A Henderson; Pyone Cho
Journal:  Am J Public Health       Date:  2014-04-22       Impact factor: 9.308

3.  Using disability adjusted life years to value the treatment of thirty chronic conditions in the U.S. from 1987 to 2010: a proof of concept.

Authors:  Tina Highfill; Elizabeth Bernstein
Journal:  Int J Health Econ Manag       Date:  2019-04-08

4.  Modeling the impact of comorbidity on breast cancer patient outcomes.

Authors:  Shengfan Zhang; Julie Simmons Ivy; Fay Cobb Payton; Kathleen M Diehl
Journal:  Health Care Manag Sci       Date:  2010-06

5.  Understanding fragmentation of prostate cancer survivorship care: implications for cost and quality.

Authors:  Ted A Skolarus; Yun Zhang; Brent K Hollenbeck
Journal:  Cancer       Date:  2011-10-05       Impact factor: 6.860

6.  Use of advanced treatment technologies among men at low risk of dying from prostate cancer.

Authors:  Bruce L Jacobs; Yun Zhang; Florian R Schroeck; Ted A Skolarus; John T Wei; James E Montie; Scott M Gilbert; Seth A Strope; Rodney L Dunn; David C Miller; Brent K Hollenbeck
Journal:  JAMA       Date:  2013-06-26       Impact factor: 56.272

7.  Guidelines for Measuring Disease Episodes: An Analysis of the Effects on the Components of Expenditure Growth.

Authors:  Abe Dunn; Eli Liebman; Lindsey Rittmueller; Adam Hale Shapiro
Journal:  Health Serv Res       Date:  2016-05-03       Impact factor: 3.402

8.  Implications of evolving delivery system reforms for prostate cancer care.

Authors:  Brent K Hollenbeck; Maggie J Bierlein; Samuel R Kaufman; Lindsey Herrel; Ted A Skolarus; David C Miller; Vahakn B Shahinian
Journal:  Am J Manag Care       Date:  2016-09       Impact factor: 2.229

9.  Variation in prostate cancer treatment and spending among Medicare shared savings program accountable care organizations.

Authors:  Parth K Modi; Samuel R Kaufman; Tudor Borza; Phyllis Yan; David C Miller; Ted A Skolarus; John M Hollingsworth; Edward C Norton; Vahakn B Shahinian; Brent K Hollenbeck
Journal:  Cancer       Date:  2018-06-15       Impact factor: 6.860

10.  Depression and ambulatory care sensitive hospitalizations among Medicare beneficiaries with chronic physical conditions.

Authors:  Rituparna Bhattacharya; Chan Shen; Usha Sambamoorthi
Journal:  Gen Hosp Psychiatry       Date:  2014-06-04       Impact factor: 3.238

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.